tiprankstipranks
Advertisement
Advertisement

CGEN Stock Latest News

Compugen Earnings Call: Cash Windfall, Trials and Risks
Company AnnouncementsCompugen Earnings Call: Cash Windfall, Trials and Risks
25d ago
CGEN
Compugen Extends Cash Runway to 2029 and Swings to Profit on AstraZeneca Deal and Clinical Progress
PremiumCompany Announcements
Compugen Extends Cash Runway to 2029 and Swings to Profit on AstraZeneca Deal and Clinical Progress
25d ago
6K
CGEN
Compugen reports Q4 EPS 60c vs. (7c) last year
PremiumThe Fly
Compugen reports Q4 EPS 60c vs. (7c) last year
25d ago
CGEN
Compugen (CGEN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Compugen (CGEN) Q4 Earnings Cheat Sheet
1M ago
CGEN
Compugen Adds Veteran Healthcare Strategist Michele Holcomb to Board of Directors
PremiumCompany Announcements
Compugen Adds Veteran Healthcare Strategist Michele Holcomb to Board of Directors
1M ago
6K
CGEN
Compugen initiated with a Buy at H.C. Wainwright
PremiumThe FlyCompugen initiated with a Buy at H.C. Wainwright
3M ago
CGEN
Compugen Secures $90 Million in a Strategic Royalty Monetization Deal with AstraZeneca
Premium
Company Announcements
Compugen Secures $90 Million in a Strategic Royalty Monetization Deal with AstraZeneca
3M ago
6K
CGEN
Compugen and AstraZeneca agree to monetize rilvegostomig future royalties
Premium
The Fly
Compugen and AstraZeneca agree to monetize rilvegostomig future royalties
3M ago
AZN
CGEN
Compugen Reports Q3 2025 Results and Clinical Progress
PremiumCompany Announcements
Compugen Reports Q3 2025 Results and Clinical Progress
5M ago
CGEN
Compugen’s Earnings Call: Strategic Focus Amid Financial Challenges
PremiumCompany Announcements
Compugen’s Earnings Call: Strategic Focus Amid Financial Challenges
5M ago
CGEN
Compugen Reports Q3 2025 Results and Advances Clinical Trials
PremiumCompany Announcements
Compugen Reports Q3 2025 Results and Advances Clinical Trials
5M ago
6K
CGEN
Compugen reports Q3 EPS (7c), consensus (9c)
PremiumThe Fly
Compugen reports Q3 EPS (7c), consensus (9c)
5M ago
CGEN
CGEN Earnings this Week: How Will it Perform?
PremiumPre-EarningsCGEN Earnings this Week: How Will it Perform?
5M ago
CGEN
Compugen’s COM701 Trial: A Potential Game-Changer in Ovarian Cancer Treatment
Premium
Company Announcements
Compugen’s COM701 Trial: A Potential Game-Changer in Ovarian Cancer Treatment
5M ago
CGEN
Compugen Presents Promising COM701 Analysis at ESMO 2025
Premium
Company Announcements
Compugen Presents Promising COM701 Analysis at ESMO 2025
5M ago
6K
CGEN
Compugen’s Shareholders Approve All Proposals at 2025 Annual Meeting
PremiumCompany Announcements
Compugen’s Shareholders Approve All Proposals at 2025 Annual Meeting
6M ago
6K
CGEN
Compugen’s Earnings Call: Strategic Gains Amid Financial Hurdles
PremiumCompany Announcements
Compugen’s Earnings Call: Strategic Gains Amid Financial Hurdles
8M ago
CGEN
Compugen’s COM701 Trial: A Potential Game-Changer in Ovarian Cancer Treatment?
PremiumCompany Announcements
Compugen’s COM701 Trial: A Potential Game-Changer in Ovarian Cancer Treatment?
8M ago
CGEN
Compugen price target raised to $13 from $10 at Leerink
PremiumThe Fly
Compugen price target raised to $13 from $10 at Leerink
8M ago
AZN
CGEN
Compugen Reports Q2 2025 Results and Strategic Progress
PremiumCompany AnnouncementsCompugen Reports Q2 2025 Results and Strategic Progress
8M ago
CGEN
Compugen Ltd. Announces 2025 Annual General Meeting Details
Premium
Company Announcements
Compugen Ltd. Announces 2025 Annual General Meeting Details
8M ago
6K
CGEN
Compugen Reports Q2 2025 Results and Advances in Immuno-Oncology Trials
Premium
Company Announcements
Compugen Reports Q2 2025 Results and Advances in Immuno-Oncology Trials
8M ago
6K
CGEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >